Please login to the form below

Not currently logged in


This page shows the latest MSD news and features for those working in and with pharma, biotech and healthcare.

AZ drug matched to cancer mutation passes phase 2 test

AZ drug matched to cancer mutation passes phase 2 test

The first approvals for type-agnostic therapies have already been granted, with Merck/MSD’s Keytruda (pembrolizumab( and Bristol-Myers Squibb’s Opdivo (nivolumab) – both PD-1 checkpoint inhibitors – greenlighted for

Latest news

More from news
Approximately 37 fully matching, plus 361 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 2 fully matching, plus 34 partially matching documents found.

Latest appointments

More from appointments
Approximately 5 fully matching, plus 56 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 26 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company

Latest intelligence

World Diabetes Day: Interaction and impact of diabetes on mental health
For World Diabetes Day on the 14th November 2018, Nisha Shahrukh - Medical Writer at Mednet Group has written an article depicting the impact diabetes has on mental health. Including...
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think
Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...